American Water (AWK) Q1 2026 Earnings Transcript

American Water Works reported adjusted EPS of $1.01, in line with expectations, and reaffirmed full-year 2026 EPS guidance of $6.02 to $6.12, implying about 8% growth. The company raised its quarterly dividend 8.2% to $0.8950 per share, secured about $185 million from PFAS manufacturers, and highlighted a roughly $84 million tax refund plus an estimated $100 million annual cash-flow benefit from CAMT changes. Management also outlined continued regulatory progress in five rate cases and merger approvals for Essential Utilities, with closing still targeted for Q1 2027.

Analysis

AWK is quietly de-risking the equity story in a way the market may not be fully underwriting: the new CAMT guidance creates a near-term cash bridge that can partially fund capex and dividends without proportionally leaning on incremental equity. That matters because regulated utilities usually trade on implied dilution risk more than on reported EPS, and a ~$100M annual cash-tax swing is large enough to change the shape of the financing plan when the company refreshes guidance in Q3.

The bigger second-order beneficiary is likely the company’s own cost of capital. A cleaner funding path plus constructive rate mechanics in multiple states should compress perceived regulatory overhang, which can support both multiple and allowed-return expectations into the second half of the year. If Pennsylvania lands as a balanced outcome in May/July, the stock could re-rate before the actual rate step-ups hit, because the market will discount the earnings inflection well ahead of reported numbers.

The main risk is that the deal-and-capex machine is still capital hungry. The balance sheet remains levered, the equity forward still needs to be absorbed, and any stumble in one or two key state proceedings would force investors back to the old question: is growth accretive after dilution, or just a more expensive way to grow rate base? The Essential deal adds optionality, but it also adds procedural risk and an outside closing clock that could keep the stock range-bound until late summer.

Consensus likely underestimates how much of this is a timing trade, not a thesis trade. In the next 2-4 months, the stock can work if investors focus on cash tax relief, rate-case cadence, and dividend signaling; over 12-18 months, the real driver is whether AWK can convert these regulatory wins into lower perceived earnings volatility. If that happens, the dividend growth story becomes a valuation support, not just a yield feature.

Key Decisions for Investors

• Long AWK into Q3 guidance refresh; use any post-call pullback to build a position ahead of the capital-plan update, with a 3-6 month catalyst window around Pennsylvania/New Jersey decisions and CAMT incorporation.
• Pair trade: long AWK / short a more levered regulated utility with heavier equity-funding risk (e.g., WTRG) for 3-9 months; AWK has the cleaner near-term cash-flow surprise, while WTRG carries more approval-timing uncertainty.
• Buy AWK Jan-2027 calls or call spreads if implied vol is reasonable; the setup is asymmetric into merger approval milestones and rate-case decisions, with upside if the market reprices lower dilution risk.
• Take profits or hedge if AWK rallies sharply before the Q3 update; the stock could front-run the good news, leaving limited upside unless management actually reduces future equity needs.